While only a small fraction of each miRNA is released in EVs expressing ASGR1—so a larger fraction may be derived from cells other than hepatocytes—these data suggest that, in NAFLD, the contribution of the liver to circulating EV-derived miRNA increases. This evidence concerns the gene ASGR1 and metabolic dysfunction-associated steatotic liver disease.